Significant Investments Secured by Dentognostics to Help Combat Periodontal Disease


Dental Innovation Alliance and Dental365 the latest to invest in company and its patented saliva analyzing product.

Significant Investments Secured by Dentognostics to Help Combat Periodontal Disease: © Dental Innovation Alliance

Significant Investments Secured by Dentognostics to Help Combat Periodontal Disease: © Dental Innovation Alliance

Dentognostics, a research-driven technology company seeking to improve patient outcomes against periodontal disease, has secured significant investments from Dental Innovation Alliance (DIA) and Dental365. The new support helps propel its growth and innovation in the U.S. dental market.

With their patented products for oral health and wellness—which include digital diagnostic readers and PerioSafe mouth rinse—Dentognostics continues to gain the trust and support of industry leaders. Pacific Dental Services (PDS) made a major investment in 2021, partnering with Dentognostics to actively explore innovative technologies including a tool to screen patients by taking a simple mouth rinse sample, within their supported practices.

Dentognostics is looking to empower patients with knowledge about what is happening in their mouth, and to understand the importance of proper dental hygiene, periodontal care, and maintenance. This is done with the company’s patented product that analyzes saliva to determine the collagen breakdown activity in the mouth.

By providing patients with a quantitative Oral Fitness Score, the company says the technology keeps the patients accountable for their daily home care behavior and allows the clinician to truly personalize the patients' care needs based on the data generated, ultimately developing trust between patients and their dental care provider.

"Supporting Dentognostics aligns perfectly with our mission at DIA, which is to foster innovation and collaboration in the dental and health sectors," says Thomas Sharpe, DIA Managing Partner, in a press release on August 9. "We firmly believe in the transformative power of Dentognostics' technology and see it as a game-changer in improving patient outcomes."

DIA is a venture firm that funds, advises, and aids the success of early-stage dental technology companies through its leadership and investor team, which has a combined 200-plus years of dental industry experience. Beyond capital, it provides mentorship and connectivity designed to enhance sales activity for portfolio companies.

"Investing in and providing other DIA resources to Dentognostics is a natural fit,” adds Doug Brown, DIA Managing Partner in the press release. “We believe in their technology and see potential in their testing to greatly improve outcomes in patients. We are excited about its potential to revolutionize patient care and elevate oral health globally."

Scott Asnis, DDS, CEO of Dental365, a full-service dental group with locations throughout New York, Connecticut, New Jersey, New Hampshire, Massachusetts, and Rhode Island has joined PDS and DIA as an investor.

"We sincerely thank Pacific Dental Services for their unwavering partnership and support over the past 2 years. Their belief in our vision has been instrumental in our growth," says Dirk-Rolf Gieselmann, Dentognostics founder and CEO. "We are equally thrilled to welcome DIA and Dental365, whose investments further strengthen our position in the industry and affirm our dedication to 14 years of research and development. Together, we are poised to revolutionize the oral health landscape and reach new heights."

Related Videos
 Product Bites – August 25, 2023
 Product Bites – August 11, 2023
 Product Bites – August 11, 2023
AHDA23 Annual Conference in 4 Minutes
5Ws* Video - Triton Traveler System
2022 Chicago Dental Society Midwinter Meeting, Interview with theFlipMirror CEO Larry Harlan, DDS
2022 Most Recommended OTC Products Guide
DPR Top 100 products 2020
© 2023 MJH Life Sciences

All rights reserved.